Zealand Pharma A Revenue per Employee (ZEAL), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Zealand Pharma A  (NASDAQ: ZEAL)
 

Zealand Pharma A's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Zealand Pharma A's Revenue per employee grew on a trailing twelve month basis to , the productivity of Zealand Pharma A's employees reached a new high of $ 750,172.
Within the Healthcare sector Employees of 50 other companies have achieved higher revenue per employee. While Zealand Pharma A's total ranking has deteriorated compared to the previous quarter from 0 to 809. Zealand Pharma A has 390 employees.


What is Sales per Employee Ratio?







ZEAL Revenue per Employee (Dec 31 2021)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter

Y / Y Revenue Change - - - - -
Sales per Employee (TTM) $ 750,172 - - - -
ZEAL's Total Ranking # 809 # 0 # 0 # 0 #
Seq. Revenue Change - - - - -


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 32
Healthcare Sector # 51
Overall Market # 809

Revenue per Employee Statistics
High Average Low
$ 750,172 $ 750,172 $ 750,172
(Dec 31 2021)  



Financial Statements
Zealand Pharma A's Revenue MRQ $ 293 Millions Visit ZEAL's Income Statement
Zealand Pharma A's Revenues TTM $ 293 Millions Visit ZEAL's aggregate revenue growth
What are ZEAL's Sales? Visit ZEAL's Sales by Segment




Other Ratios
Zealand Pharma A's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ZEAL's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ZEAL's Competitors
Revenue per Employee for ZEAL's Suppliers
Revenue per Employee for ZEAL's Customers

You may also want to know
ZEAL's Sales Growth Rates ZEAL's Pe Price to earnings ratio ZEAL's Receivables Turnover Ratio ZEAL's Stock Quote
ZEAL's Net Income Growth Rates ZEAL's Ps Price to Sales ratio ZEAL's Sales per Employee ZEAL's Asset Turnover Ratio
ZEAL's Net Margin ZEAL's Pb Price to Book ratio ZEAL's Financial Strength Ratios ZEAL's Dividend Payout Ratio
Date modified: 2026-06-22T16:58:57+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2021, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2021Number of Employees Dec 31 2021
Seagen Inc   1,311,975.83 $ 1,574.371  Million 1,200 
Regenxbio Inc   1,267,781.67 $ 470.347  Million 371 
Acorda Therapeutics Inc   1,265,401.96 $ 129.071  Million 102 
Exelixis Inc   1,251,063.64 $ 1,434.970  Million 1,147 
Integrated Biopharma Inc  1,229,500.00 $ 61.475  Million 50 
United Therapeutics Corporation  1,203,928.57 $ 1,685.500  Million 1,400 
Lipocine Inc   1,152,917.00 $ 16.141  Million 14 
Cartesian Therapeutics Inc   1,134,360.00 $ 85.077  Million 75 
Akebia Therapeutics Inc   1,100,917.53 $ 213.578  Million 194 
Scienture Holdings Inc   1,098,825.89 $ 9.889  Million
Journey Medical Corp  1,088,517.24 $ 63.134  Million 58 
Pfizer Inc  1,083,840.00 $ 81,288.000  Million 75,000 
Palvella Therapeutics Inc   1,083,379.31 $ 31.418  Million 29 
Jazz Pharmaceuticals Plc  1,070,670.59 $ 3,094.238  Million 2,890 
Minerva Surgical Inc   1,063,326.53 $ 52.103  Million 49 
Xencor Inc  1,058,119.23 $ 275.111  Million 260 
Incyte Corporation  1,050,023.56 $ 2,986.267  Million 2,844 
Halozyme Therapeutics Inc   1,048,014.18 $ 443.310  Million 423 
Regeneron Pharmaceuticals Inc   1,042,939.65 $ 16,071.700  Million 15,410 
Harmony Biosciences Holdings inc   1,042,457.34 $ 305.440  Million 293 
Endo International Plc  1,021,223.47 $ 2,993.206  Million 2,931 
Cytomx Therapeutics Inc   1,008,304.35 $ 69.573  Million 69 
Abiomed Inc   1,003,148.00 $ 1,003.148  Million 1,000 
Abbvie Inc   985,912.28 $ 56,197.000  Million 57,000 
Pharming Group N v   984,509.90 $ 198.871  Million 202 
Intercept Pharmaceuticals inc   969,248.00 $ 363.468  Million 375 
Collegium Pharmaceutical Inc   953,000.00 $ 403.119  Million 423 
Lifevantage Corp  949,596.41 $ 211.760  Million 223 
Alpine Immune Sciences Inc   937,720.00 $ 23.443  Million 25 
Shockwave Medical Inc   937,335.97 $ 237.146  Million 253 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.